![Kimberly Gentile](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kimberly Gentile
Directeur Technique/Scientifique/R&D chez BIOHAVEN LTD.
Fortune : 3 M $ au 30/06/2024
Profil
Mme Kimberly Gentile est vice-présidente principale des opérations cliniques chez Biohaven Pharmaceutical Holding Co. Ltd. et directrice des opérations chez Portage Pharmaceutical Ltd. Mme Gentile était auparavant employée en tant que directrice associée chez Bristol Myers Squibb Co. et en tant que Senior Manager-Clinical Trail chez SCIREX Corp. Elle a obtenu son diplôme de premier cycle à la Salem State University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
BIOHAVEN LTD.
0,11% | 04/03/2024 | 95 969 ( 0,11% ) | 3 M $ | 30/06/2024 |
Postes actifs de Kimberly Gentile
Sociétés | Poste | Début |
---|---|---|
BIOHAVEN LTD. | Directeur Technique/Scientifique/R&D | - |
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Directeur des opérations | - |
Anciens postes connus de Kimberly Gentile
Sociétés | Poste | Fin |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Directeur/Membre du Conseil | 03/10/2022 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/02/2014 |
SCIREX Corp. | Corporate Officer/Principal | 01/06/2000 |
Formation de Kimberly Gentile
Salem State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
BIOHAVEN LTD. | Health Technology |
Entreprise privées | 3 |
---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
![]() Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
SCIREX Corp. | Commercial Services |
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |